Compare OPK & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPK | SSII |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | India |
| Employees | N/A | 378 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 855.2M |
| IPO Year | 2011 | N/A |
| Metric | OPK | SSII |
|---|---|---|
| Price | $1.21 | $4.69 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $2.03 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 121.2K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.75 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.11 | $3.02 |
| 52 Week High | $2.04 | $14.29 |
| Indicator | OPK | SSII |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 50.84 |
| Support Level | $1.12 | $3.14 |
| Resistance Level | $1.27 | $5.00 |
| Average True Range (ATR) | 0.04 | 0.55 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 60.71 | 70.51 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.